HMGCR and cerebrovascular disorder: Statin medication is widely recognized as a class of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, which is widely used in the treatment of hyperlipidemia and the prevention of cardiovascular and cerebrovascular diseases (Bibbins-Domingo et al., 2016).